536 related articles for article (PubMed ID: 3518930)
41. [Circulating immune complexes and immunologic reactivity in breast cancer].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
[TBL] [Abstract][Full Text] [Related]
42. [Simultaneous occurrence of breast cancer, causing disseminated metastases after 32 years verified by immunohistochemistry, and cured malignant melanoma].
Nádasdy T; Gyöngyösy M; Krenács T
Orv Hetil; 1988 Dec; 129(51):2743-6. PubMed ID: 3064024
[No Abstract] [Full Text] [Related]
43. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
44. [Behavior of some tumor markers (secretory immunoglobulin A, pregnancy-associated alpha 2-glycoprotein, circulating immune complexes in the serum of patients with breast tumors].
Briese V; Strache RR; Büttner HH; Kunze M; Brock J; Röpcke G
Zentralbl Gynakol; 1987; 109(5):265-73. PubMed ID: 3591061
[TBL] [Abstract][Full Text] [Related]
45. Immune complexes in human melanoma: a consequence of deranged immune regulation.
Jerry LM; Rowden G; Cano PO; Phillips TM; Deutsch GF; Capek A; Hartmann D; Lewis MG
Scand J Immunol; 1976; 5(6-7):845-59. PubMed ID: 981971
[TBL] [Abstract][Full Text] [Related]
46. [Detection of circulating immune complexes by polyethyleneglycol precipitations complement consumption test in urological malignant diseases].
Sakai S; Kato N; Ito Y; Matsuda S; Koide T; Deguti T; Kuriyama M; Ban Y; Nishiura T; Tei K
Hinyokika Kiyo; 1984 Nov; 30(11):1611-7. PubMed ID: 6543290
[TBL] [Abstract][Full Text] [Related]
47. Circulating immune complexes in breast and lung cancer, before and after chemotherapy.
García MS; Barañao RI; Fernández O; Bordenave H; Rumi LS
Allergol Immunopathol (Madr); 1987; 15(1):15-8. PubMed ID: 3604838
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance and nature of circulating immune complexes in melanoma patients.
Gupta RK; Morton DL
Contemp Top Immunobiol; 1985; 15():1-53. PubMed ID: 3896641
[No Abstract] [Full Text] [Related]
49. Circulating immune complexes in patients with melanoma.
Sztaba-Kania M; Jassem J; Piskorzyńska M; Kondrat W
Neoplasma; 1981; 28(4):491-6. PubMed ID: 7027060
[TBL] [Abstract][Full Text] [Related]
50. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
Grosser N; Thompson DM
Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
[TBL] [Abstract][Full Text] [Related]
51. Circulating immune complexes in patients following clinically curative resection of colorectal cancer.
Steele G; Sonis S; Stelos P; Rittgers R; Zamcheck N; Finn D; Maltz J; Mayer R; Lokich J; Wilson RE
Surgery; 1978 Jun; 83(6):648-54. PubMed ID: 205963
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
Das TK; Aziz M; Rattan A; Sherwani R
J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
[TBL] [Abstract][Full Text] [Related]
53. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
Das S
Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
[TBL] [Abstract][Full Text] [Related]
54. Uses and limitations in the demonstration of specific circulating immune complexes in patients with amoebiasis.
Vinayak VK; Shandil RK; Bansal V; Singh K; Bhasin DK; Kaur U
J Med Microbiol; 1990 Jun; 32(2):87-91. PubMed ID: 2355392
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
Aziz M; Akhtar S; Malik A
Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
[TBL] [Abstract][Full Text] [Related]
56. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
[TBL] [Abstract][Full Text] [Related]
57. Changes of circulating immune complexes in the serum and CSF of patients with multiple sclerosis.
Cojocaru M; Cojocaru MI; Steriu O; Băldescu R
Rom J Intern Med; 1992; 30(1):51-6. PubMed ID: 1496259
[TBL] [Abstract][Full Text] [Related]
58. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
[TBL] [Abstract][Full Text] [Related]
59. Specific circulating immune complexes in amoebic liver abscess.
Vinayak VK; Purnima ; Singh K; Venkatwswarlu K; Nain CK; Mehta SK
J Clin Microbiol; 1986 Jun; 23(6):1088-90. PubMed ID: 2872230
[TBL] [Abstract][Full Text] [Related]
60. Circulating immune complexes in malignant melanoma.
Gupta RK
Dis Markers; 1988 Jun; 6(2):81-95. PubMed ID: 3042263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
